Literature DB >> 5809740

The pharmacology of fenclozic acid (2-(4-chlorophenyl)-thiazol-4-ylacetic acid; I.C.I. 54,450; 'Myalex'); a new compound with anti-inflammatory, analgesic and antipyretic activityl.

B B Newbould.   

Abstract

1. Fenclozic acid (2-(4-chlorophenyl)thiazol-4-ylacetic acid; I.C.I. 54,450; "Myalex") is one representative of a new class of compounds with antiinflammatory, analgesic and antipyretic properties as evidenced by its activity in a variety of tests in rats, mice and guinea-pigs.2. In tests of short duration the potency of fenclozic acid is similar to that of phenylbutazone.3. In tests of longer duration fenclozic acid is more potent than phenylbutazone.4. The activity of fenclozic acid is not mediated by stimulation of the adrenals and the compound is devoid of corticosteroid-like activity.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5809740      PMCID: PMC1703354          DOI: 10.1111/j.1476-5381.1969.tb08290.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  THE USE OF CHANGES IN CAPILLARY PERMEABILITY IN MICE TO DISTINGUISH BETWEEN NARCOTIC AND NONNARCOTIC ALALGESICS.

Authors:  B A WHITTLE
Journal:  Br J Pharmacol Chemother       Date:  1964-04

2.  Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs.

Authors:  C A WINTER; E A RISLEY; G W NUSS
Journal:  Proc Soc Exp Biol Med       Date:  1962-12

3.  A study of pharmacological influences on ultraviolet erythema in guinea pigs.

Authors:  C V WINDER; J WAX; V BURR; M BEEN; C E ROSIERE
Journal:  Arch Int Pharmacodyn Ther       Date:  1958-09-01

4.  Development of arthritis, periarthritis and periostitis in rats given adjuvants.

Authors:  C M PEARSON
Journal:  Proc Soc Exp Biol Med       Date:  1956-01

Review 5.  Indomethacin: a survey of clinical trials.

Authors:  W M O'Brien
Journal:  Clin Pharmacol Ther       Date:  1968 Jan-Feb       Impact factor: 6.875

6.  2-(4-chlorophenyl)thiazol-4-ylacetic acid('Myalex'): a new compound with anti-inflammatory,, analgesic and antipyretic activity.

Authors:  W Hepworth; B B Newbould; D S Platt; G J Stacey
Journal:  Nature       Date:  1969-02-08       Impact factor: 49.962

7.  Metabolism of thiazole acetic acid derivatives and the NIH shift.

Authors:  D M Foulkes
Journal:  Nature       Date:  1969-02-08       Impact factor: 49.962

8.  Immunosuppressive activity of 3-acetyl-5-(4-fluorobenzylidene)-4-hydroxy-2-oxo-2:5-dihydrothiophen (I.C.I. 47,776).

Authors:  G E Davies
Journal:  Immunology       Date:  1968-03       Impact factor: 7.397

9.  A new type of cytotoxic immunosuppressive agent: 3-acetyl-5-(4-fluorbenzylidiene)4-hydroxy-2-oxo-2:5-dihydrothiophen.

Authors:  T J Franklin; B B Newbould; D M O'Mant; A I Scott; G J Stacey; G E Davies
Journal:  Nature       Date:  1966-05-07       Impact factor: 49.962

10.  CHEMOTHERAPY OF ARTHRITIS INDUCED IN RATS BY MYCOBACTERIAL ADJUVANT.

Authors:  B B NEWBOULD
Journal:  Br J Pharmacol Chemother       Date:  1963-08
View more
  4 in total

1.  Improved hepatic physiology in hepatic cytochrome P450 reductase null (HRN™) mice dosed orally with fenclozic acid.

Authors:  James A Akingbasote; Alison J Foster; Huw B Jones; Rhiannon David; Nigel J Gooderham; Ian D Wilson; J Gerry Kenna
Journal:  Toxicol Res (Camb)       Date:  2016-11-09       Impact factor: 3.524

2.  Anti-inflammatory and related properties of 2-(2,4-dichlorophenoxy)phenylacetic acid (fenclofenac).

Authors:  D C Atkinson; E C Leach
Journal:  Agents Actions       Date:  1976-09

3.  Synergistic effect of Kalpaamruthaa on antiarthritic and antiinflammatory properties--its mechanism of action.

Authors:  Rajendran Mythilypriya; Palanivelu Shanthi; Panchanadam Sachdanandam
Journal:  Inflammation       Date:  2008-12       Impact factor: 4.092

4.  Pharmacology of an extract of salai guggal ex-Boswellia serrata, a new non-steroidal anti-inflammatory agent.

Authors:  G B Singh; C K Atal
Journal:  Agents Actions       Date:  1986-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.